Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · March 16, 2022

Clinical Risk Factors for Immune Checkpoint Inhibitor–Induced Type 1 Diabetes

Diabetes Care


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Care
Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
Diabetes Care 2022 Mar 03;[EPub Ahead of Print], X Chen, AH Affinati, Y Lee, AF Turcu, NL Henry, E Schiopu, A Qin, M Othus, D Clauw, N Ramnath, L Zhao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading